Experimental peptide drug shows promise against acute myeloid leukemia

[News]

In a study published online today in Science Translational Medicine, Albert Einstein College of Medicine researchers report that an experimental peptide drug shows promise against the often-lethal cancer acute myeloid leukemia and describe how the drug works at the molecular level.

More... (https://www.news-medical.net/news/20180411/Experimental-peptide-drug-shows-promise-against-acute-myeloid-leukemia.aspx)